With a market cap of has a large market cap size. Zoetis Inc. (NYSE: ZTS) has been on the stock market since its IPO date on the 2/1/2013. Zoetis Inc. is in the Drugs – Generic industry and Healthcare sector. Average volume for Zoetis Inc., is 3086.6, and so far today it has a volume of 33265. Performance year to date since the 2/1/2013 is 9.40%.
To help you determine whether Zoetis Inc. is undervalued the following values will help you decide. P/E is 40.7 and forward P/E is 22.58. PEG perhaps more useful shows that Zoetis Inc. has a value for PEG of 3.24. P/S ratio is 5.32 and the P/B ratio is 19.08. The P/Cash and P/Free cash flow is 39.26 and 52.72 respectively.
At the current price Zoetis Inc. is trading at, 52.12 (0.06% today), Zoetis Inc. has a dividend yield of 0.73%, and this is covered by a payout ratio of 35.10%. Earnings per share (EPS) is 1.28, and this is looking to grow in the next year to 21.55% after growing -41.90% this past year. EPS growth quarter over quarter is 707.10%, and 2.80% for sales growth quarter over quarter.
The number of shares outstanding is 495.9, and the number of shares float is 494.52. The senior management bring insider ownership to 0.01%, and institutional ownership is at 92.90%. The float short is 1.28%, with the short ratio at a value of 2.04. Management has seen a return on assets of 8.60%, and also a return on investment of 5.70%.
The ability for Zoetis Inc., to deal with debt, means it current ratio is 3.2, and quick ratio is 1.7. Long term debt/equity is 3.29 and total debt/equity is 3.29. In terms of margins, Zoetis Inc. has a gross margin of 64.90%, with its operating margin at 20.70%, and Zoetis Inc. has a profit margin of 13.20%.
The 52 week high is -0.69%, with 39.28% being its 52 week low. The 20 day simple moving average is 6.42% and the 200 day simple moving average is 13.56%.
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.